Week Ending May 24, 2021

What is the impact of hepatitis C on pregnancy?
“Most people with hepatitis C who become pregnant have a healthy pregnancy in which the hepatitis C virus (HCV) does not transmit to the fetus. However, hepatitis C may add to the risks of pregnancy.”

A Proclamation on National Hepatitis Testing Day, 2021
“Our efforts to combat the COVID-19 pandemic over the past year have reinforced many public health lessons, including the importance of communication, community engagement, and a comprehensive testing strategy to reduce the spread of infection.”

Hepatitis C testing, treatment down during the pandemic
“The COVID-19 pandemic reduced routine hepatitis C virus (HCV) testing and treatment, according to a study published online May 10 in the American Journal of Preventive Medicine.”

Testing and treatment for hepatitis C in children
“Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). If the infection becomes chronic, it can lead to liver damage over time. However, hepatitis C in children is treatable and often responds well to medication.”

Opt-Out Increases Hepatitis C Screening Uptake
“Twice as many eligible patients get screened for hepatitis C virus (HCV) if it is already ordered for them at the time of a reminder, according to a study published online May 18 in The BMJ.”

Discriminatory Sobriety Restrictions Undermine Public Health Efforts to Eliminate Hepatitis C
“The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) today released a new progress report detailing the changes to hepatitis C treatment access in Medicaid programs since first publishing an analysis in 2017. The Hepatitis C: State of Medicaid Access May 2021 National Progress Report (Progress Report) demonstrates that while there is better access to hepatitis C (HCV) treatment today, discriminatory practices persist in some state Medicaid programs. In particular, sobriety restrictions continue to undermine public health efforts to eliminate hepatitis C in the U.S.”

When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins
“Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with cure rates above 95%.”